Company Filing History:
Years Active: 2016
Title: Marja Kanning: Innovator in Cognitive and Nutritional Science
Introduction: Marja Kanning, based in Basel, Switzerland, is a noteworthy inventor with a focus on nutritional science and cognitive enhancement. With a patent under her name, Kanning’s work explores the application of tryptophan-rich protein hydrolysates to improve various aspects of human function and well-being.
Latest Patents: Kanning holds a patent for her innovative method that utilizes tryptophan-containing di- and/or tri-peptide mixtures derived from egg lysozyme hydrolysates. This method aims to promote feelings of energy, cognitive function, quality of sleep, and overall well-being in healthy adults. The patent highlights a unique Trp/LMAA ratio greater than 0.15, ensuring efficacy with doses of up to 100 mg of tryptophan per serving. The dosage can be administered either acutely or in multiple doses throughout the day, making it an adaptable solution for enhancing cognitive and physical performance.
Career Highlights: Throughout her career, Marja has been involved in pioneering research that bridges the gap between nutrition and cognitive health. Her innovative approach sets her apart in the scientific community, particularly in how nutritional elements can influence mental states and physical well-being.
Collaborations: Kanning collaborates closely with renowned colleagues, including Leigh Gibson and Regina Goralczyk. Their combined expertise strengthens the research and development efforts at DSM IP Assets B.V., where Kanning contributes her knowledge and innovative spirit.
Conclusion: Marja Kanning's contributions to nutritional science and cognitive enhancement demonstrate the significant impact that innovative research can have on improving human health. Her patent represents a stepping stone towards understanding and harnessing the power of nutrition in fostering better cognitive functions and overall well-being.